JamJar Investments is a venture capital fund set up by the three founders of Innocent Drinks.
The London healthtech startup secured backing from Balderton and Pentland to scale manufacturing and regulatory pathways for its continuous glucose monitor.
"During their time at Imperial, they worked in one of the pioneering research groups that invented modern glucose strip technology. Their combined expertise in electrochemistry, biosensing, and medical device engineering laid the foundation for Sava’s next-generation biosensor platform."
The funding round was led by JamJar Investments, with backing from Active Partners and Animal Health Angels.
"Marleybones is driven by our founding mission of making dogs healthier and happier. This investment will allow us to continue delivering on that promise and caring for more dogs than ever before. Having seen the benefits on my own dog Marley, and the customers we’re lucky enough to serve, we’re excited about what this investment unlocks for our community"
JamJar leads the £5m round to help the running coaching application develop artificial intelligence capabilities.
"I felt a huge sense of privilege to get to work with up to 40 private clients at a time before launching Runna, helping them to be healthier and happier. Now having been able to build a service to deliver a better experience, at a tenth of the price, to over 50 thousand people is hard to get my head around."
The funding round was led by JamJar Investments and brings the company's total money raised to £7.8m.
"Solo travel has continued to grow in popularity as people look to expand their horizons and make up for lost time, but in the last two years, we have also seen an increased appetite for building meaningful connections through travel. We’re proud to be doing our part in helping to make cities like London less isolated, with 80% Flashpackers staying in touch after their trip. The recent investment indicates the value in this growing trend and we’re incredibly excited to continue this success worldwide."
The funding round was led by Octopus Ventures with backing from JamJar and Forward Partners.
"This latest injection of funding – from experienced investors with a proven track record of backing successful fertility and femtech businesses – will enable us to get our pioneering treatment in the hands of the people who need it most. We can’t wait for people to try it."
